Vedolizumab

CAS 943609-66-3Biologic

Overview

Vedolizumab is a humanized monoclonal antibody used in the treatment of ulcerative colitis and Crohn's disease. It works by blocking the migration of white blood cells into the gut, thereby reducing inflammation.

Therapeutic areas

GastroenterologyImmunologyInflammation
Verified Supplier Partner

Do you supply Vedolizumab? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Related APIs

Azathioprine
12 suppliers
Sulfasalazine
6 suppliers
Lansoprazole
32 suppliers
Pantoprazole
28 suppliers
Celecoxib
27 suppliers
Mesalamine
27 suppliers
Vonoprazan Fumarate
25 suppliers
Budesonide
24 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.

Start free trialBook a demo